Technology | August 02, 2011

GE’s latest Radiotherapy Simulation CT Systems Target Cancer

August 2, 2011 – As the 2011 American Association of Physicists in Medicine (AAPM) and Canadian Organization of Medical Physicists (COMP) meet in Vancouver, Canada, GE Healthcare announced the recent U.S. Food and Drug Administration (FDA) clearance and increasing global utilization of its new platform of radiotherapy (RT) planning computed tomography (CT) systems. Highlighted by the Discovery CT590 RT, these CT systems are designed specifically with treatment planning in mind and help physicians address the increasingly specialized imaging needs of patients.

GE’s new wide-bore RT portfolio – including the Discovery CT590 RT and Optima CT580 RT – is dedicated to meeting both current and future clinical oncology demands for diagnostic accuracy, enhanced visualization, complex patient positioning and monitoring, and productive workflow.

Built from the ground up and flexible in a variety of radiation oncology settings, the new RT systems are powered by the latest in GE CT technology. For example, the Discovery CT590 RT offers an automated 4-D video organ motion-recording feature, which captures organ movement to better adapt future radiation therapy treatments.

“As new treatment technologies emerge in radiotherapy, there is an increasing need for intuitive imaging systems supported by robust clinical applications and reliable service,” said Randy Hemingway, administrative director of radiation oncology at Washington Hospital Center in Washington, D.C. “Our new Discovery CT590 RT with Advantage 4-D and Advantage SimMD offer just such benefits – helping us improve workflow with accuracy as we seek optimal clinical outcomes that best meet our patients’ needs.”  

In addition to imaging for oncology, this new family of RT products will also be available for interventional and bariatric CT. In fact, the Discovery CT590 RT can leverage GE’s leading dose reduction technology called ASiR (adaptive statistical iterative reconstruction). This reconstruction technology may enable reduction in pixel noise standard deviation and improvement in low contrast detectability, and may allow for reduced mA in the acquisition of diagnostic images, thereby reducing the dose required. +

+ In clinical practice, the use of ASiR may reduce CT patient dose depending on the clinical task, patient size, anatomical location and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task.

For more information: www.gehealthcare.com

 

 

Related Content

ASTRO and ASCO Launch New Cancer Care Quality Registry
News | Radiation Therapy | January 22, 2018
January 22, 2018 — A registry that tracks the quality of medical care provided to patients receiving cancer treatment
First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
Overlay Init